## Abstract Significant progress in understanding the mechanisms leading to the development of acute myeloid leukemia (AML) has led to the identification of numerous molecular abnormalities that may be responsible for leukemogenesis. Over the same period, large trials have established standard regi
Progress in the treatment of childhood acute leukemia: A review
β Scribed by Steinhorn, Sandra C. ;Myers, Max H.
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 784 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The dramatic improvements in the survival experience for children diagnosed with acute leukemia are analyzed using data collected through hospitals participating in the National Cancer Institute's End Results Group Program between 1950 and 1973. Children under 15 years of age who were diagnosed with both acute lymphocytic leukemia (ALL) and acute nonlymphocytic leukemia (ANLL) showed moderate improvements in the 1950s, but beginning in the 1960s those with ALL did far better. Statistically significant differences at the 0.05 level were noted between their threeβyear survival rates for all cohorts analyzed between 1960 and 1973. For the 1970β1973 cohort, threeβyear survival rates were 49% and 20% for ALL and ANLL, respectively, and fiveβyear survival rates were 34% and 12%. Between 1950 and 1976 the ageβadjusted incidence rate for all childhood leukemias remained relatively stable in a sample of five geographic areas, changing from 4.6 per 100,000 children under 15 years of age to 4.3 per 100,000. In contrast, the corresponding ageβadjusted mortality rate fell approximately 45% over the same period, from 4.4 per 100,000 to 2.4 per 100,000.
π SIMILAR VOLUMES